Assessment B-Cell-Activating Factor (BAFF) in thrombocytopenia patients

被引:0
|
作者
Al-Fatlawi, Noor Alhuda Ghanem [1 ]
Al-Dujaili, Arshad N. G. [2 ]
Kammona, Talib Hussein Nooruldeen [3 ]
机构
[1] Univ Kufa, Fac Sci, LAB Invest, Kufa, Iraq
[2] Univ Kufa, Fac Sci, Kufa, Iraq
[3] Univ Kufa, Fac Med, Kufa, Iraq
关键词
ANTIBODY-PRODUCTION; DISEASE; FAMILY;
D O I
10.1063/5.0027533
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Thrombocytopenia is a reduction in circulating platelet levels. Primary thrombocytopenia or idiopathic or immune thrombocytopenia purpura (ITP) is an autoimmune disorder of unknown cause affecting both children and adults and thrombocytopenia that a result from a known condition is called secondary thrombocytopenia. The B-Cell Activating Factor (BAFF) belonging to the tumor necrosis factor (TNF) superfamily are key actors for the B-cell survival then the immune responses concerning mature B-cells BAFF and APRIL are concerned of the pathogenesis of a variety of human autoimmune diseases. To discover the pathophysiologic characteristic concerning BAFF within thrombocytopenia we investigated serum level of BAIT ITP and secondary thrombocytopenia. The study was applied on 85 people aged 20 to 69 year; 65 patients group with thrombocytopenia and 30 healthy group as a control group. The group of patients was divided into subgroups based on gender, age, body mass index (BMI), primary and secondary thrombocytopenia. the complete blood count were examined for all patients group and healthy group. BAFF serum level was significantly decrease (P>0.05) in thrombocytopenia patients than controls. Primary thrombocytopenia show nonsignificant decrease (P>0.05) in BAFF serum compare with secondary thrombocytopenia. The results exhibited non a significant increase (P>0.05) in serum BAFF level in female compared with male thrombocytopenia patients and indicated non-significant differences (P>0.05) in serum BAH level of patients at different ages group and different types of body mass index (normal weight, over weight and obese weight) respectively. The results of correlation and linear regression indicated a significant negative (P<0.05) correlation between BAIT and platelets and significant positive(P<0.05) correlation between BAFF and leucocytes counts in primary thrombocytopenia,while significant positive(P<0.05) correlation between BAFF and platelets concentrations and non-significant positive (P>0.05) correlation BAFF and leucocytes counts in secondary thrombocytopenia. Current study was aimed to determine BAFF which can be used for diagnosis and prognosis of ITP.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Functional and Clinical Aspects of the B-Cell-Activating Factor (BAFF): A Narrative Review
    Lied, G. A.
    Berstad, A.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (01) : 1 - 7
  • [2] Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia
    Min, Y. -N.
    Wang, C. -Y.
    Li, X. -X.
    Hou, Y.
    Qiu, J. -H.
    Ma, J.
    Shao, L. -L.
    Zhang, X.
    Wang, Y. -W.
    Peng, J.
    Hou, M.
    Shi, Y.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (03) : 559 - 571
  • [3] Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils
    Scapini, Patrizia
    Bazzoni, Flavia
    Cassatella, Matco A.
    [J]. IMMUNOLOGY LETTERS, 2008, 116 (01) : 1 - 6
  • [4] Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus
    Vincent, F. B.
    Kandane-Rathnayake, R.
    Hoi, A. Y.
    Slavin, L.
    Godsell, J. D.
    Kitching, A. R.
    Harris, J.
    Nelson, C. L.
    Jenkins, A. J.
    Chrysostomou, A.
    Hibbs, M. L.
    Kerr, P. G.
    Rischmueller, M.
    Mackay, F.
    Morand, E. F.
    [J]. LUPUS, 2018, 27 (13) : 2029 - 2040
  • [5] Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis
    Thangarajh, M
    Gomes, A
    Masterman, T
    Hillert, J
    Hjelmström, P
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 152 (1-2) : 183 - 190
  • [6] RETREATMENT WITH RITUXIMAB IN ANTI-MAG POLYNEUROPATHY: IS THE B-CELL-ACTIVATING FACTOR (BAFF) A NEGATIVE PROGNOSTIC FACTOR?
    Garnero, M.
    Franciotta, D.
    Briani, C.
    Campagnolo, M.
    Grandis, M.
    Fabbri, S.
    Beronio, A.
    Mancardi, G. L.
    Schenone, A.
    Benedetti, L.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 : S19 - S19
  • [7] CHARACTERIZATION OF A UNIQUE B-CELL-ACTIVATING FACTOR
    THOMAN, MT
    HOBBS, MV
    WEIGLE, WO
    [J]. LYMPHOKINE RESEARCH, 1987, 6 (01): : U133 - U133
  • [8] B-cell-activating factor (BAFF) and platelet-activating factor (PAF) in pregnancies complicated by maternal obesity and diabetes: a preliminary study
    Neri, Caterina
    Ciliberti, Alessandra
    Dessi, Davide Archelao
    Airoldi, Chiara
    Basello, Katia
    Costanzi, Andrea
    Familiari, Alessandra
    Tersigni, Chiara
    Cappelletti, Mattia
    Speciani, Attilio Francesco
    Lanzone, Antonio
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2023, 36 (02):
  • [9] PURIFICATION AND PROPERTIES OF HUMAN B-CELL-ACTIVATING FACTOR
    WOOD, DD
    [J]. JOURNAL OF IMMUNOLOGY, 1979, 123 (05): : 2395 - 2399
  • [10] Genetic Variation in Promoter Sequence of B-Cell-Activating Factor of the TNF Family (BAFF) in Patients with Idiopathic Inflammatory Myopathies (IIM)
    Faustova, M.
    Plestilova, L.
    Hulejova, H.
    Pecha, O.
    Betteridge, Z.
    Mann, H.
    Putova, I.
    Vencovsky, J.
    Novota, P.
    Krystufkova, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A51 - A52